This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Gambia

  1. PATH is on the front lines of an effort to defeat meningitis by 2030.
    Published: April 2019
    Type: Article
  2. This fact sheet provides an overview of the MVP Access Program, an initiative that grants researchers access to data sets and frozen serum samples collected during the MenAfriVac ® clinical studies in Africa. The fact sheet outlines MenAfriVac's ® development history, qualified uses of data, and how to request data and/or serum access.
    Published: October 2018
    Type: Resource Page
  3. Perspectives from a mom, an immunization manager, and clinical investigators.
    Published: November 2017
    Type: Article
  4. Two clinicians reflect on evaluating early vaccines in The Gambia
    Published: November 2017
    Type: Article
  5. Perspectives from The Gambia’s immunization program manager
    Published: November 2017
    Type: Article
  6. One mother’s story about enrolling her child in a vaccine trial.
    Published: November 2017
    Type: Article
  7. PATH and its partners have been conducting clinical trials to evaluate a pneumococcal vaccine designed to meet needs in low-resource countries.
    Published: November 2017
    Type: Article
  8. Mark Alderson won’t rest easy until he solves one of the biggest problems in global health: a vaccine against pneumonia.
    Published: June 2016
    Type: Article